We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

PamGene Enters Co-Marketing Agreement with Invitrogen in Nuclear Hormone Receptor Drug Discovery

News   Jan 17, 2008

 
PamGene Enters Co-Marketing Agreement with Invitrogen in Nuclear Hormone Receptor Drug Discovery
 
 
 

RELATED ARTICLES

Probing Yeast Cells to Understand Cell Misregulation

News

Manipulating yeast with optogenetics and microfluidics to explore the MAP kinase pathway may be key for drug discovery.

READ MORE

Existing Drug Could Treat Porphyria

News

An existing antifungal drug, ciclopirox (CPX), has been shown to improve symptoms associated with congenital erythropoietic porphyria – the rarest type of porphyria.

READ MORE

Scientists Develop New Drug Treatment for TB

News

Scientists at The University of Manchester have developed the first non-antibiotic drug to successfully treat tuberculosis in animals. The team hope the compound –developed after 10 years of painstaking research will be trialed on humans within three to four years.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE